AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene

Journal of Immunology

Volumn 156, Issue 10, 1996, Pages 3780-3787

  López Rodríguez, Cristina ^a   Kluin Nelemans, Hanneke C ^b   Corbí, Angel L ^c  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; CELL ADHESION MOLECULE; FIBRINOGEN; GLYCOPROTEIN P 15095; INTEGRIN; L SELECTIN; LIPOPOLYSACCHARIDE; PROTEIN C FOS; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION;

BASE SEQUENCE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INTEGRIN ALPHAXBETA2; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LYMPHOMA, LARGE-CELL; MOLECULAR SEQUENCE DATA; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029968320     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301
2. Arnaout, M A. 1990. Leukocyte adhesion molecules deficiency its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol. Rev 114:145.
3. Postigo, A. A., A L. Corbí, F. Sanchez-Madrid, and M. O. de Landázuri. 1991. Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes: relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18. J Exp. Med. 174:1313.
4. Loike, J. D., B. Sodeik, L. Cao, S. Leucona, J. I. Weitz, P. A. Detmers, S. D. Wright, and S. C. Silverstein 1991 CD11c/CD18 on neutrophils recognize a domain at the N terminus of the Aα chains of fibrinogen. Proc. Natl. Acad Sci. USA 88:1044
5. Ingalls, R. R., and D D Golenbock. 1995. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J. Exp. Med. 181:1473.
6. Bilsland, C. A. G., M. S. Diamond, and T. A. Springer. 1994 The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b: activation by a heterologous β subunit and localization of a ligand recognition site to the I domain. J. Immunol. 152:4582.
7. Anderson, D. C , L. J. Miller, F C Schmalstieg, R. Rothlein, and T. A. Springer 1986. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte function, structure-function assessments employing subunit-specific monoclonal antibodies. J. Immunol 137:15.
8. Davis, G E. 1992. The Mac-1 and p150,95 β2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp. Cell Res. 200:242.
9. Keizer, G. D., J. Borst, W. Visser, R. Schwarting, J. E. de Vries, and C. G. Figdor. 1987. Membrane glycoprotein p150,95 of human cytotoxic T cell clones is involved in conjugate formation with target cells. J. Immunol. 138 3130.
10. Stacker, S. A , and T. A Springer. 1991. Leukocyte integrin p150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J. Immunol. 146:648
11. Kishimoto, T. K., R. S. Larson, A L. Corbi, M. L. Dustin, D. E. Staunton, and T. A Springer. 1989. The leukocyte integrins. Adv. Immunol. 46:149.
12. Kansas, G. S., M. J. Muirhead, and M. O. Dailey. 1990 Expression of the CD11c/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 76:2483.
13. Schwarting, R., H. Stein, and C. Y. Wang. 1985. The monoclonal antibodies αS-HCL1 (αLeu-14) and αS-HCL3 (αLeu-M5) allow the diagnosis of hairy cell leukemia. Blood 65:974.
14. Hanson, C. A., T. E. Gribbin, B. Schnitzer, J. A. Schlegelmich, B. S. Mitchell, and L. M. Stoolman. 1990. CD11c (Leu-M5) expression characterizes a B cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood 76:2360
15. Mohammad, R. M., A. Al-katib, G. R. Petit, and L L. Sensenbrenner. 1993. Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines. Leuk. Res. 17.1.
16. Bellón, T., C López-Rodríguez, M A. Rubio, G. Jochems, C. Bernabeu, and A. L. Corbí. 1994. Regulated expression of p150,95 (CD11c/CD18; αX/β2) and VLA-4 (CD49d/CD29; α4/β1) integrins during myeloid cell differentiation. Eur. J. Immunol. 24:41
17. Lubbert, M., F. Herrmann, and H. P. Koeffler. 1991. Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. Blood 77:909
18. Lopez-Cabrera, M., A. Nueda, A. Vara, J. G. Aguilar, A Tugores, and A. L. Corbí. 1993 Characterization of the p150,95 leukocyte integrin α subunit (CD11c) gene promoter: identification of cis-acting sequences. J. Biol. Chem 268:1187
19. Rius, C., C. Cabaãs, and P Aller 1990. The inducton of vimentin gene expression by sodium butyrate in human promonocytic leukemia U937 cells. Exp Cell Res. 188:129.
20. Pahl, H. L., R. J Scheibe, D. E. Zhang, H. M. Chen, D. L. Galson, R. A. Maki, and D. G. Tenen. 1993. The protooncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J. Biol Chem. 268.5014.
21. Kunkel, T. A., J. D Roberts, and R A. Zakour. 1987. Rapid and efficient site-directed mutagenesis without phenotypic selection Methods Enzymol 154.367.
22. Schreiber, E , P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419
23. Sambrook, J., E. F Fristsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
24. Mueller, P. R., and B. Wold. 1989. In vivo footprinting for a muscle specific enhancer by ligation-mediated PCR. Science 246:780.
25. Chiu, R., P Angel, and M. Karin. 1989. JunB differs in its biological properties from, and is a negative regulator of, c-jun. Cell 59:979.
26. Angel. P , and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys Acta 1072:129.
27. Konig, H , H. Ponta, H. J. Rahmsdorf, and P. Herrlich 1992. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol-ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11:2241.
28. Rubio, M. A., C. López-Rodríguez, A Nueda, P. Aller, A. L. Armesilla, M. A. Vega, and A. L. Corbí. 1995 Granulocyte/Macrophage colony-stimulating factor, phorbol ester and sodium butyrate induce the CD11c integrin gene promoter activity during myeloid cell differentiation. Blood 86:3715.
29. Karin, M 1994. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin Cell Biol. 6:415.
30. Mollinedo, F., C. Gajate, A Tugores, I. Flores, and J R Naranjo. 1993. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes Biochem. J. 294:137.
31. William, F., F. Wagner, M. Karin, and A. S. Kraft. 1990. Multiple doses of diacylglycerol and calcium ionophore are necessary to activate AP-1 enhancer activity and induce markers of macrophage differentiation. J. Biol. Chem. 265.18166.
32. Mitcheli, R L., L. Zokas, R. D Schreiber, and I. M. Verma 1985. Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation. Cell 40:209.
33. Colotta, F., J M. Wang, N. Polentarutti, and A. Mantovani. 1987. Expression of c-fos protooncogene in normal human peripheral blood granulocytes. J Exp. Med 165:1224.
34. Sariban, E., T Mitchell, A Rambaldi, and D. W. Kufe. 1988. c-sis but not c-Fos gene expression is lineage-specific in human myeloid cells. Blood 71:488.
35. Mavilio, F., U. Testa, N M. Sposi, M Petrini, E. Pelosi, C. Bordignon, S Amadori, F. Mandelli, and C. Peschle. 1987 Selective expression of c-fos protooncogene in human acute myelomonocytic and monocytic leukemias: a molecular marker of terminal differentiation. Blood 69:160.
36. Pinto, A., G Colletta, L. del Vecchio, R. Rosati, V. Attadia, R. Cimino, and A. Colombatti 1987. c-fos oncogene expression in human hematopoietic malignancies is restricted to acute leukemias with monocytic phenotype and to subsets of B cell leukemias. Blood 70:1450
37. Huo, L., and T. L. Rothstein 1995. Receptor-specific induction of individual AP-1 components in B lymphocytes J. Immunol 154:3300
38. Shelley, C. S., and M. A. Arnaout. 1991. The promoter of the CD11b gene directs myeloid-specific and developmentally regulated expression. Proc Natl Acad Sci. USA 88:10525
39. Wu, H , K. Moulton, A. Horval, S. Parik, and C. K Glass. 1994 Combinatorial interactions between AP-1 and ets domain protein contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol. Cell. Biol 14:2129.
40. Antalis, T. M , and J. A. Reeder. 1995. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells. Int. J. Cancer 62:619.
41. + T cells in vivo J. Immunol. 154:5684.
42. Bottinger, E. P., C. S. Shelley, O. C. Farokhzad, and M. A. Amaout. 1994. The human β2 integrin CD18 promoter consists of two inverted Ets cis elements. Mol Cell. Biol. 14:2604.
43. Wang, C.-Y., A G Bassuk, L H. Boise, C. B. Thompson, R Bravo, and J. M. Leiden. 1994. Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors Mol. Cell Biol. 14:1153.
44. Gottsschalk, L R , D. M. Giannola, and S. G. Emerson. 1993. Molecular regulation of the human IL-3 gene, inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites. J. Exp. Med. 178:1681.
45. Moulton, K. S , K. Semple, H. Wu, and C. K. Glass. 1994. Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU 1 and a composite AP-1/ets motif. Mol. Cell. Biol. 14.4408
46. Fischer, A , W. Friedrich, A. Fasth, S Blanche, F. Le Deist, D. Girault, F. Veber, J Vossen, M. Lopez, C Griscelli, and M Hirm 1991. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteoporosis, and Fanconi's anemia: a European group for immunodeficiency/European group for bone marrow transplantation report. Blood 77 249.
47. Kerppola, T. K., D. Luk, and T Curran 1993. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro Mol. Cell Biol. 13:3782.